Print Page | Sign In | Join Today
Focus Around Virginia
Blog Home All Blogs
A Word from Jeff Gallagher, CEO, Virginia Bio It’s my privilege to travel the state and meet hundreds of companies, research institutions, and individuals who are doing fascinating innovative work and making valuable contributions to our economy and to the health and well-being of people around the globe. Every month in this blog I’ll take a short look at an outstanding member of Virginia’s bioscience community, or update you on important information that impacts the community.

 

Search all posts for:   

 

Top tags: virginia bioscience  Virginia bio  funding  government  Economic Development  Governor  thrive  21st century cure  big data  commercialization  DARPA  federal  policy  Research  STEM  Todd Haymore  vabio  #biotech  #veterans #vamedicalcenter #g2gconsulting #biotech  agriculture  Biological  convention  IALR  Inova  Institute for Advanced Learning and Research  intern  JP Morgan Healthcare Conference  jpmorgan  medimmune  students 

Accelerating Progress in Virginia Bioscience Commercialization

Posted By Administration, Wednesday, September 23, 2015
Updated: Tuesday, September 22, 2015
Members and friends of Virginia Bio,

A sage cautioned “don’t confuse familiarity with understanding.”

Many of us are familiar with the research and commercialization parks and accelerators which are available for biotech commercialization around the state. But don’t blink, and don’t stop asking questions, because the facilities we know are evolving, and new resources are developing across the state to meet the great opportunity bioscience commercialization presents for the Commonwealth.

Let’s start with an update on the Prince William County Science Accelerator at Innovation Park. This space, opened in June 2014, offers leading life science and biotechnology companies 9 wet labs to grow their business at an intersection of university research and commercialization. This accelerator is the only public-private, commercially available wet laboratory space in Northern Virginia, located less than an hour away from key government buildings such as the National Institute of Health and the FDA.

Already, the accelerator is moving fast. ISOThrive LLC, a leader in nutritional ingredients that benefit the gut microbiome, expanded into larger lab space within the accelerator this past April. Since then, it has partnered with George Mason University’s MicroBiome Analysis Center to push along their research into the commercialization process. In addition to ISOThrive, two other companies, Ceres Nanosciences and Virongy, make use of the county’s accelerator. Ceres endeavors to seize the future of diagnostics by researching and commercializing novel sample processing techniques. Virongy, a virological reagent and tool company, provides cutting-edge services that catalyze scientific discoveries, enhance disease treatments, and more.

In Richmond, the Virginia Biotechnology Research Park, to strengthen its role in leading bioscience commercial innovation, has transitioned the Virginia Biotechnology Research Park Corporation Board to The Innovation Council. With an emphasis on innovation and entrepreneurship, the Council, a 501-c(3) entity with 19 members, will seek to leverage individuals and organizations doing groundbreaking work in order to ensure commercial success and benefit the state economy at large. The Council boasts leaders in business, education, and other fields as part of their membership, and also received a helping hand from Dr. Rao, President of Virginia Commonwealth University in the form of a $1.2 million dollar commitment to be matched with other sources of funding.

In Danville, the Institute for Advanced Learning and Research recently completed a strategic reevaluation, and a focus on translational research and support of entrepreneurs and commercialization rose to the top. Its top notch research facilities, leaseholds and common facilities are a great home for the right bio business. IALR’s mix of labs, office and meeting facilities was a perfect spot to host the highly successful statewide Governor’s Forum on Agriculture and Industrial Bio earlier this month.

In Virginia Beach, an impressive year long, community wide economic development planning process, led by the city’s Mayor and top corporate leaders, has recommended an emphasis on biomedical industry development, and designated a 150+ acre tract adjacent to LifeNet Health and Sentara Princess Anne to set aside as biomedical research and commercialization park. Early steps in the plan call for the development thereof a bioscience accelerator.

Back to Northern Virginia, the plans for Inova’s Center for Personalized Health on the massive campus formerly the home to ExxonMobil continue to take shape. The public announcements and interviews are exciting, and it’s clear that an integral element of the campus will be facilities and services to house and support biomedical and biotech startups.

Another new, and very different, player on the scene is the new LiftOff Health, in Arlington, that is accelerating commercial expansion and networking by functioning as a digital platform of collaboration/incubation, with dreams of serving and attracting any entrepreneur around the world. This approach appears at first glance to fit companies in mobile health and e-health - involved in the “creative destruction of medicine”, as Eric Topol, director of the Scripps Translational Science Institute, puts the impact of wireless and Internet on medicine and research. Awarables, for example, is a company using LiftOff Health which provides men and women who suffer from chronic sleep disorders an app that tracks details about their sleep patterns.

Check out other parks and accelerators you may be familiar with across the state, and equip yourself with up to date information: Virginia Tech’s impressive Corporate Research Center “CRC” in Blacksburg, UVA Research Park in Charlottesville, Innovation Research Park at ODU, and Innovation Village @ Rockingham by SRI Shenandoah Valley among others. In fact, click here to view our VA Life Sciences Map. On the top row of the map window, choose the Snapshots button, then select Research Park or Accelerator Organization Types to view all together.

We are picking up the pace and getting smarter about creating on the “Virginia Common” the physical and expert resources needed by researchers and entrepreneurs to succeed in commercializing bioscience innovations. The accelerators, incubators and parks are diversifying and providing more value, helping to propel the biotechnology industry into the future, which is looking bright. That means more jobs, more cures and more health for the commonwealth.

Best Regards,



Jeff Gallagher
CEO

Tags:  accelerator  Ceres  commercialization  Economic Development  IALR  Innovation council  Inova  Institute for Advanced Learning and Research  ISOThrive  LifeNet  LiftOff  MicroBiome  prince william  Research  Scripps  Sentara  SRI Shenandoah  Virginia bio  virginia bioscience  virginia biotech  Virongy 

Share |
Permalink
 

THRIVE 2015: Where We Go From Here

Posted By Administration, Thursday, May 21, 2015
Updated: Thursday, May 21, 2015
Members and friends of Virginia Bio,

Thanks to each and every one of you who supported or attended THRiVE 2015, making our statewide conference a tremendous success by every measure.

Over 350 people attended throughout the day, both members and future members. You can enjoy scores of photos, plus press coverage plus most of the power point presentations of the day on our THRiVE conference webpage.

We networked morning, noon and night.

We made valuable contacts and heard from experts in a wide variety of fields.

We spoke in one voice to the Governor, Secretaries and legislators about transformationally improving how the state supports bioscience commercialization in Virginia. Thanks to the many industry and university members of the Governor’s Working Groups and public servants who made that unique event possible.

Together, we assembled and celebrated the largest gathering ever of Virginians, harnessing the power of data science for the biomedical enterprise.

And we provided a forum for the leaders of the Northern Virginia bioscience community to come together, at this time of so much growth by individual organizations and companies.

Most importantly, by doing this well, we further developed opportunities to work together to create the future of bioscience in Virginia.

So we will be busy.

In state public policy, over the next nine months we will be informing, counselling and advocating to the Administration and General Assembly a coherent package of policies and programs that will make a dramatic impact on biosciences in Virginia. We will need your help.

Starting immediately, we will be working with companies, universities, the state and other organizations to weave our strengths together and accelerate the momentum in the big data space. This is uncharted territory, with great upside. We will need your help.

And going forward, we will continue to increase our programming in Northern Virginia, to help our members and partners their reach their enormous potential and weave them together with the rich opportunities across the Commonwealth. We will need your help.

The explosion of scientific knowledge, the transformation of the delivery of health care on account of reimbursement, big data and mobile technology, the globalization of knowledge …. We live in interesting times. And we will be measured, individually and collectively, by how we respond to these extraordinary challenges and opportunities.

Virginia Bio looks forward to this wonderful challenge, because we are part of wonderful community of members and friends, and the work we are about is of such critical value to the Common wealth.

Best Regards,




Jeff Gallagher
CEO

Tags:  commercialization  Economic Development  government  Governor  policy  Thrive  Virginia bio  virginia bioscience 

Share |
Permalink
 

Virginia's Historic Strategic Opportunity

Posted By Jeff Gallagher, Thursday, September 25, 2014

Members and friends of Virginia Bio,

The convergence of bio with IT and big data is well described. Indeed most of you know it firsthand. This week I seemed to see it everywhere I went. To start with, a global pharma company’s 4 hour briefing on its future vision of new drug development – one planted on deep phenotyping and proven specific biomarkers requiring the skills and technologies of big data. Later, I met two different startup companies, one in diagnostics and the other in neuroimaging, and both based on a facility and intelligence in gathering, shaping and gaining insights from massive datasets. I’ve had or heard conversations with health care providers striving to harness those same technologies and capabilities to mine clinical records and real world data to discover how to deploy bio, pharma, device and diagnostic innovations to select the most effective care to patients and to provide it efficiently.

Like many others, I believe this convergence presents our members, the Virginia bioscience community, and the Commonwealth itself, with an historic strategic opportunity because of Virginia’s unrivaled IT/big data assets and expertise. I want Virginia Bio to do everything we can to accelerate and enable this convergence, to grow our bioscience industry and to help our talent here take a place at the leading edge across the nation and world.

Very soon we will be announcing details for our next statewide gathering on April 23, 2015 at the Westfields Marriott, in Chantilly. When 550 of us met last year in Charlottesville, we celebrated all you have achieved over the past twenty years. Next spring, we want to take that enthusiasm and focus it forward. One goal of the event, given the special opportunity provided by the northern Virginia setting, is to bring Virginia bio and big data/IT communities - researchers, companies, investors, consultants, together in a way never been done before. Let’s shine light on needs, opportunities and capabilities, make new contacts and build that community.

We’re using our Virginia Bio Commercialization luncheon series to push this goal too. Recall that this monthly event, though staged in Richmond, is available to members through live streaming statewide and archived in the video library on our website. The program on October 9 will be "The sky is the limit: the data-driven, data-smart bioscience organization.” Experts will challenge the audience with ideas and examples to use the latest in data tools, techniques and strategies to transform your biotech company to become all it can be – strategic, innovative, competitive, effective, efficient and insightful in a way never before possible. Panelists include Jay Goldman, Managing Director Sensei Labs, senior leader Klick Health, and co-author of the New York Times bestseller The Decoded Company, and Lewis Broome, CEO of Data Blueprint, a Richmond-based data management consulting firm. Go to our Community Calendar page for more details and to register.

I would love to hear from you with ideas about other ways Virginia Bio can help Virginia join the lead in this extraordinary new age of bioscience research and commercialization.


Best Regards,

 

Jeff Gallagher
CEO

 

Tags:  big data  commercialization  Data Blueprint  Klick Health  Sensei Labs  The Decoded Company  virginia bioscience 

Share |
Permalink
 

Our Premium Partners

Sign up for our newsletter
800 E. Leigh St.  |  Richmond, Va 23219-1534  |  PH: 804.643.6360  |  Email Us
Stay Connected